Retatrutide Long-Term: Why I'm Not Staying On It Forever

You know, a lot of people say I'll be on Reddit TrueTide forever, and I understand why that sounds reasonable, because the drug works, the weight comes off, appetite goes quiet, and the idea of giving that up feels like walking away from the only thing that ever worked.

But before we get into whether staying on it forever makes sense, you need to understand what the drug is actually doing inside your body, because most people talking about this online have no idea what makes retatrutide different from what came before it.

Your gut releases hormones after you eat, and those hormones travel to your pancreas and your brain and tell your body two things: release insulin to handle the incoming glucose, and stop eating because food has arrived. One of those hormones is called GLP-1, which is glucagon-like peptide-1, and it slows how fast your stomach empties while also acting on the hunger centers in your hypothalamus. Another is called GIP, glucose-dependent insulinotropic polypeptide, which works on insulin release and also seems to affect how fat tissue handles the energy you send it.

Semaglutide works on that first hormone alone, while tirzepatide reaches both of them at once.

Retatrutide hits a third receptor on top of those, the glucagon receptor, and glucagon is the hormone your body normally uses to pull stored energy back out of your liver and your fat when blood sugar drops. Activating it deliberately raises how much energy you burn at rest, which is the part that separates retatrutide from everything else in this class. You are not just eating less, you are also spending more.

That triple action is why the numbers look the way they do. In the phase 2 data reviewed by Katsi and colleagues in Biomolecules in 2025, participants on the highest dose lost around 24 percent of their body weight at 48 weeks, and the weight loss curve had still not flattened out when the trial ended, which means nobody actually knows where the ceiling is.

For comparison, the systematic review by Kokkorakis and colleagues in Pharmacological Reviews in 2025 puts tirzepatide in the 20 to 21 percent range and semaglutide closer to 15 percent over similar timeframes. So retatrutide is the strongest thing anyone has tested in this category, and it is still not approved, which matters more than people want to admit.

I think that part of the reason why they want to be on Reddit forever has more to do with the fact that they're treating it like a fucking pacifier that gives them an excuse to not have to fully commit to the habits necessary to maintain the results.

The drug suppresses appetite and it does not teach you how to grocery shop, portion your protein, sleep enough to keep your hunger hormones regulated, or train hard enough to hold onto muscle while you are in a deficit. The suppression covers for all of that, and as long as it is covering, you never have to build the skill underneath.

Then they are married to it because of the, say, long-term health benefits, because we really don't have any long-term health data on Reddit.

And I want to be careful here, because the argument for long-term health benefits is not made up. The cardiovascular outcome data on semaglutide is real, the reduction in major adverse cardiac events is real, and it is entirely reasonable to look at that and think this class of drug does more than shrink waistlines. On that point, the people making the argument are right.

The problem is that retatrutide is not semaglutide. It has a third mechanism that semaglutide does not have, and the longest data we have on it is measured in months, not years. Nobody has run retatrutide out to five years in a large population and looked at what happens to the heart, the kidneys, the pancreas, or the gallbladder.

For all we know, there's going to be some type of commercials, like the ones that we see on Mesothelioma, about if you were on Reddit TrueTide, call this number.

That is a joke, and it is also not entirely a joke, because that is exactly how the timeline works with drugs. The efficacy signal shows up first, in trials that run 48 weeks and enroll a few thousand people. The rare adverse events show up years later, in populations of millions, after the drug has been in the wild long enough for a one-in-ten-thousand problem to become visible.

The known side effect profile so far is mostly gastrointestinal, nausea and vomiting and diarrhea, dose-dependent and worse during escalation. There were also increases in heart rate observed in the trials, which is consistent with what glucagon agonism does to metabolic rate, and that is the kind of finding that needs years of follow-up before anyone can say whether it matters.

None of that means the drug is dangerous. The record is simply still being written, one trial at a time.

So the practical question becomes how you use something with a strong short-term effect and an unfinished safety record, and the answer runs through dose.

Because we don't have that long-term data, because we want to maintain the lowest effective dose to get the benefit that we're looking for, in my mind, it's use the Retta, stay low, go slow, scale up as needed, be pragmatic about it.

The reason low dosing works better than people expect is that the appetite suppression saturates before the side effects do. Most of the reduction in food intake happens at doses well below the maximum, and the extra milligrams buy you a smaller and smaller amount of additional hunger control while the nausea and the heart rate response keep climbing.

In the phase 2 program, even the lower dose arms produced weight loss that would have been considered outstanding for any other drug five years ago. So if 2 milligrams is dropping your appetite and your weight is moving, going to 8 milligrams is buying you side effects you did not need.

Think about it the way you would think about a thermostat. You are not trying to run the heat at maximum, you are trying to hold a temperature, and once the room is where you want it, cranking the dial higher does not make it more comfortable, it just burns more fuel and makes the room unpleasant.

Stay at the lowest dose that is still moving the needle, and only go up when the needle stops moving, and even then go up in the smallest increment available and give it three or four weeks before you judge it.

And then when you reach your goal weight, just scale back down and work your way to come off of it.

This is the part almost nobody plans for, and it is where the habits either exist or they do not. Coming off the drug means your appetite comes back, your gastric emptying speeds up, and the metabolic rate bump from the glucagon receptor goes away, and if the only thing holding your intake down was the injection, your intake goes back up the week you stop.

So the taper is not really about the taper. It is about giving yourself a window where the appetite is returning gradually while you are still practicing the eating pattern you intend to keep, so that by the time the drug is fully out of your system you have several weeks of evidence that you can hold your weight without it.

Which means the work during the drug phase is different from what most people are doing. Get your protein high enough to protect lean mass while you are in a deficit, because losing weight fast on a suppressed appetite is how people end up smaller and weaker with a lower resting metabolism than they started with. Train with resistance work hard enough to keep that muscle a reason for your body to hang onto. Track what you are actually eating, even though you do not feel like you need to, precisely because you will need to know the number later when hunger comes back.

After that stretch of work, step away from the drug entirely for a couple of months.

And during those couple months you find out what you actually built, and this is where the whole thing stops being about the drug at all.

Let's say you slipped up on your diet or you want to lose more weight or whatever the case may be.

Now you have this as a tool in your toolkit that you can come back to instead of basically complaining because you're not getting the benefit from it.

That last part is worth sitting with, because there is a real physiological reason it works this way. Receptor systems adapt to continuous stimulation, and the people who ride the maximum dose for eighteen months straight are the ones who show up in forums saying the drug stopped working and they need something stronger. They have nowhere left to go, because they spent the whole range already.

The person who used 2 milligrams, got to their weight, tapered off, and lived at maintenance for four months still has the entire dose range available, plus a body that has not been continuously receptor-saturated, plus four months of practice eating like someone who does not need a drug.

When they come back for a twelve-week block to clean up a slip, it works, and it works at a low dose, and they come off again.

That is the difference between a person who is dependent on retatrutide and a person who owns it.

The strongest weight loss drug ever tested is going to spend the next decade being studied, and the studies will tell us things we cannot know today. Until then, the amount of that drug in your body is the one variable you control completely, and the smallest amount that works is always the one with the least unknown attached to it.

References:

Katsi V, Koutsopoulos G, Fragoulis C et al.. Retatrutide-A Game Changer in Obesity Pharmacotherapy. Biomolecules. 2025. https://pubmed.ncbi.nlm.nih.gov/40563436/

Kokkorakis M, Chakhtoura M, Rhayem C et al.. Emerging pharmacotherapies for obesity: A systematic review. Pharmacol Rev. 2025. https://pubmed.ncbi.nlm.nih.gov/39952695/